BIOMAT Database Logo BIOMAT Database Logo

Mutagenicity of metronidazole: structure-activity relationships. 1976

H S Rosenkranz, and W T Speck, and J E Stambaugh

UI MeSH Term Description Entries
D008795 Metronidazole A nitroimidazole used to treat AMEBIASIS; VAGINITIS; TRICHOMONAS INFECTIONS; GIARDIASIS; ANAEROBIC BACTERIA; and TREPONEMAL INFECTIONS. 2-Methyl-5-nitroimidazole-1-ethanol,Bayer 5360,Clont,Danizol,Flagyl,Gineflavir,Metric,MetroGel,Metrodzhil,Metrogyl,Metronidazole Hydrochloride,Metronidazole Monohydrochloride,Metronidazole Phosphate,Metronidazole Phosphoester,Satric,Trichazol,Trichopol,Trivazol,Vagilen,2 Methyl 5 nitroimidazole 1 ethanol
D009153 Mutagens Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. Clastogen,Clastogens,Genotoxin,Genotoxins,Mutagen
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D006639 Histidine An essential amino acid that is required for the production of HISTAMINE. Histidine, L-isomer,L-Histidine,Histidine, L isomer,L-isomer Histidine
D012486 Salmonella typhimurium A serotype of Salmonella enterica that is a frequent agent of Salmonella gastroenteritis in humans. It also causes PARATYPHOID FEVER. Salmonella typhimurium LT2
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

H S Rosenkranz, and W T Speck, and J E Stambaugh
Mutagenicity of azo dyes: structure-activity relationships.
September 1992, Mutation research,
H S Rosenkranz, and W T Speck, and J E Stambaugh
Mutagenicity of nitroxyl compounds: structure-activity relationships.
October 1992, Toxicology letters,
H S Rosenkranz, and W T Speck, and J E Stambaugh
Quantum mechanical quantitative structure-activity relationships to avoid mutagenicity.
January 2009, Dental materials : official publication of the Academy of Dental Materials,
H S Rosenkranz, and W T Speck, and J E Stambaugh
Salmonella mutagenicity and rodent carcinogenicity: quantitative structure-activity relationships.
July 1990, Mutation research,
H S Rosenkranz, and W T Speck, and J E Stambaugh
Quantitative structure-activity relationships for predicting mutagenicity and carcinogenicity.
August 2003, Environmental toxicology and chemistry,
H S Rosenkranz, and W T Speck, and J E Stambaugh
Mutagenicity studies of benzidine and its analogs: structure-activity relationships.
August 2000, Toxicological sciences : an official journal of the Society of Toxicology,
H S Rosenkranz, and W T Speck, and J E Stambaugh
The importance of analyzing structure-activity relationships in mutagenicity studies.
November 1989, Mutation research,
H S Rosenkranz, and W T Speck, and J E Stambaugh
Mutagenicity of metronidazole.
May 1979, Lancet (London, England),
H S Rosenkranz, and W T Speck, and J E Stambaugh
Mutagenicity of metronidazole.
March 1979, Lancet (London, England),
H S Rosenkranz, and W T Speck, and J E Stambaugh
Mutagenicity of metronidazole.
February 1979, Lancet (London, England),
Copied contents to your clipboard!